TYPE 1 DIABETES MELLITIS
Clinical trials for TYPE 1 DIABETES MELLITIS explained in plain language.
Never miss a new study
Get alerted when new TYPE 1 DIABETES MELLITIS trials appear
Sign up with your email to follow new studies for TYPE 1 DIABETES MELLITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug aims to control type 1 diabetes early
Disease control Recruiting nowThis study tests a new drug, CNP-103, in people aged 12 to 35 who were diagnosed with stage 3 type 1 diabetes within the last 6 months. The goal is to see if the drug is safe and can help control the disease. Participants will receive either the drug or a placebo, and researchers…
Matched conditions: TYPE 1 DIABETES MELLITIS
Phase: PHASE1, PHASE2 • Sponsor: COUR Pharmaceutical Development Company, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New insulin pump system put to the test in 400-Person safety trial
Disease control Recruiting nowThis study is checking if a new insulin pump (NMX8) and continuous glucose monitor (DS5/Simplera Sync) are safe for people with type 1 or type 2 diabetes. About 400 participants, ages 7 to 85, will first wear the sensor for up to 40 days, then use the pump for about 90 days while…
Matched conditions: TYPE 1 DIABETES MELLITIS
Phase: NA • Sponsor: Medtronic MiniMed, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
New insulin GZR33 aims to improve diabetes control
Disease control Recruiting nowThis early-stage trial is testing a new long-acting insulin called GZR33 in 12 adults with type 1 diabetes. The goal is to see how well it controls blood sugar compared to an existing insulin, degludec, and to check its safety. Participants will receive both insulins at different…
Matched conditions: TYPE 1 DIABETES MELLITIS
Phase: PHASE1 • Sponsor: Gan and Lee Pharmaceuticals, USA • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC